Squarepoint Portfolio holdings
AUM
$45.5B
1-Year Return
6.73%
This Quarter Return
-11.1%
1 Year Return
+6.73%
3 Year Return
+22.51%
5 Year Return
+41.07%
10 Year Return
+76.91%
AUM
$10.9B
AUM Growth
-$2.58B
(-19%)
Cap. Flow
-$250M
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
9.63%
Holding
2,881
New
655
Increased
724
Reduced
660
Closed
762
Top Buys
| 1 |
CSX Corp
CSX
|
+$88.7M |
| 2 |
Ulta Beauty
ULTA
|
+$71.1M |
| 3 |
Sherwin-Williams
SHW
|
+$70.2M |
| 4 |
McDonald's
MCD
|
+$65.8M |
| 5 |
Home Depot
HD
|
+$65.2M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$150M |
| 2 |
Zoom
ZM
|
+$122M |
| 3 |
Citigroup
C
|
+$102M |
| 4 |
Snap
SNAP
|
+$98.2M |
| 5 |
Apple
AAPL
|
+$91M |
Sector Composition
| 1 | Consumer Discretionary | 20.69% |
| 2 | Technology | 17.85% |
| 3 | Industrials | 10.5% |
| 4 | Healthcare | 10.43% |
| 5 | Financials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Diageo
DEO
$56.5B
| $618K | ﹤0.01% |
+3,550
| New | +$618K |
|
1277
Live Oak Bancshares
LOB
$1.67B
| $618K | ﹤0.01% |
18,235
-5,036
| -22% | -$171K |
|
1278
Novartis
NVS
$240B
| $618K | ﹤0.01% |
7,312
-7,095
| -49% | -$600K |
|
|
VERV
1279
DELISTED
Verve Therapeutics
VERV
| $618K | ﹤0.01% |
40,417
+11,035
| +38% | +$169K |
|
1280
Skillz
SKLZ
$109M
| $617K | ﹤0.01% |
24,870
-3,669
| -13% | -$91K |
|
1281
Kodiak Sciences
KOD
$489M
| $615K | ﹤0.01% |
80,514
-292,575
| -78% | -$2.23M |
|
1282
Melco Resorts & Entertainment
MLCO
$3.75B
| $615K | ﹤0.01% |
106,977
+68,177
| +176% | +$392K |
|
|
CYXT
1283
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $615K | ﹤0.01% |
54,259
+1,264
| +2% | +$14.3K |
|
1284
Idacorp
IDA
$6.77B
| $614K | ﹤0.01% |
5,800
-422
| -7% | -$44.7K |
|
|
LSXMK
1285
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $614K | ﹤0.01% |
21,993
-21,552
| -49% | -$602K |
|
1286
Guidewire Software
GWRE
$21.3B
| $609K | ﹤0.01% |
8,574
-75,077
| -90% | -$5.33M |
|
1287
Malibu Boats
MBUU
$629M
| $605K | ﹤0.01% |
11,471
-18,092
| -61% | -$954K |
|
1288
Axcelis
ACLS
$2.69B
| $598K | ﹤0.01% |
10,907
-275
| -2% | -$15.1K |
|
1289
AdvanSix
ASIX
$576M
| $598K | ﹤0.01% |
17,895
+6,332
| +55% | +$212K |
|
1290
Methanex
MEOH
$3.04B
| $595K | ﹤0.01% |
15,559
+4,773
| +44% | +$183K |
|
1291
Relay Therapeutics
RLAY
$688M
| $593K | ﹤0.01% |
35,431
+14,505
| +69% | +$243K |
|
1292
Avis
CAR
$5.47B
| $590K | ﹤0.01% |
4,012
-2,669
| -40% | -$393K |
|
1293
Direxion Daily Regional Banks Bull 3X Shares
DPST
$719M
| $589K | ﹤0.01% |
2,445
+1,563
| +177% | +$377K |
|
1294
Oil States International
OIS
$341M
| $588K | ﹤0.01% |
108,501
+65,164
| +150% | +$353K |
|
|
SRRA
1295
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $586K | ﹤0.01% |
10,656
+957
| +10% | +$52.6K |
|
1296
Schwab US Dividend Equity ETF
SCHD
$71.5B
| $584K | ﹤0.01% |
+24,474
| New | +$584K |
|
1297
Orion
OEC
$521M
| $583K | ﹤0.01% |
37,547
-80,466
| -68% | -$1.25M |
|
1298
XPeng
XPEV
$19.9B
| $581K | ﹤0.01% |
+18,307
| New | +$581K |
|
1299
CVB Financial
CVBF
$2.77B
| $580K | ﹤0.01% |
+23,375
| New | +$580K |
|
|
JBGS
1300
JBG SMITH
JBGS
$1.45B
| $579K | ﹤0.01% |
24,485
-3,301
| -12% | -$78.1K |
|